Literature DB >> 15882981

Nuclear localization signal of ING4 plays a key role in its binding to p53.

Xin Zhang1, Ke-Sheng Wang, Zhi-Qin Wang, Lu-Sheng Xu, Qing-Wan Wang, Fei Chen, Dong-Zhi Wei, Ze-Guang Han.   

Abstract

ING4, a novel member of ING family, is recently reported to interact with tumor suppressor p53 and negatively regulate the cell growth with significant G2/M arrest of cell cycle in HepG2 cells through upregulation of p53-inducible gene p21. However, which region of ING4 could have contributed to the binding to p53 remains largely unclear. Herein, the GST-pulldown experiments revealed that the middle region of ING4, a potential bipartite nuclear localization signal (NLS), could be involved in the binding to p53. Furthermore, the interaction of ING4 to p53 was abrogated in vitro and in vivo when certain mutations or the entire deletion of the NLS domain occurred. More interestingly, the mutations of the NLS domain could alter the ING4 nuclear localization, disrupt the interaction of ING4 with p53, and even, deregulate the p53-inducible gene p21 in MCF-7 cells. All data indicated that the NLS domain of ING4 is essential for the binding of ING4 to p53 and the function of ING4 associated with p53.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15882981     DOI: 10.1016/j.bbrc.2005.04.023

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  32 in total

Review 1.  The ING family tumor suppressors: from structure to function.

Authors:  Almass-Houd Aguissa-Touré; Ronald P C Wong; Gang Li
Journal:  Cell Mol Life Sci       Date:  2010-08-29       Impact factor: 9.261

2.  A dominant mutant allele of the ING4 tumor suppressor found in human cancer cells exacerbates MYC-initiated mouse mammary tumorigenesis.

Authors:  Suwon Kim; Alana L Welm; J Michael Bishop
Journal:  Cancer Res       Date:  2010-05-25       Impact factor: 12.701

3.  Histone Deacetylase Inhibitor RGFP109 Overcomes Temozolomide Resistance by Blocking NF-κB-Dependent Transcription in Glioblastoma Cell Lines.

Authors:  Zong-Yang Li; Qing-Zhong Li; Lei Chen; Bao-Dong Chen; Bo Wang; Xie-Jun Zhang; Wei-Ping Li
Journal:  Neurochem Res       Date:  2016-09-08       Impact factor: 3.996

4.  ING4 enhances paclitaxel's effect on colorectal cancer growth in vitro and in vivo.

Authors:  Liyu Cao; Shunhua Chen; Cong Zhang; Cong Chen; Nana Lu; Yan Jiang; Yongping Cai; Yu Yin; Jianming Xu
Journal:  Int J Clin Exp Pathol       Date:  2015-03-01

5.  Identification of the inhibitor of growth protein 4 (ING4) as a potential target in prostate cancer therapy.

Authors:  Aymen Shatnawi; Sridhar A Malkaram; Tamer Fandy; Efrosini Tsouko
Journal:  Mol Cell Biochem       Date:  2019-11-27       Impact factor: 3.396

6.  Association between the expression of inhibitor of growth family member 4 and the progression of clear cell renal carcinoma.

Authors:  Yuxin Ren; Song Zhao; He Chen; Ying-Mei Fu; Bai Zhao
Journal:  Oncol Lett       Date:  2017-06-21       Impact factor: 2.967

7.  Downregulated expression of inhibitor of growth 4 (ING4) in advanced colorectal cancers: a non-randomized experimental study.

Authors:  Qi You; Xi-Shan Wang; Song-Bin Fu; Xiao-Ming Jin
Journal:  Pathol Oncol Res       Date:  2011-05-31       Impact factor: 3.201

Review 8.  ING proteins as potential anticancer drug targets.

Authors:  M Unoki; K Kumamoto; C C Harris
Journal:  Curr Drug Targets       Date:  2009-05       Impact factor: 3.465

Review 9.  The ING gene family in the regulation of cell growth and tumorigenesis.

Authors:  Andrew H Coles; Stephen N Jones
Journal:  J Cell Physiol       Date:  2009-01       Impact factor: 6.384

10.  Curcumin induces G2/M cell cycle arrest in a p53-dependent manner and upregulates ING4 expression in human glioma.

Authors:  Enyu Liu; Jing Wu; Weidong Cao; Jianning Zhang; Weiping Liu; Xiaofan Jiang; Xiang Zhang
Journal:  J Neurooncol       Date:  2007-06-27       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.